# China NMPA Drug Inspection - Sinopharm Group Weichida Pharmaceutical Co., Ltd. - Amoxicillin Clavulanate Potassium Tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sinopharm-group-weichida-pharmaceutical-co-ltd/5decee3f-1a69-4911-b3b3-be4a01b832d6/
Source feed: China

> China NMPA drug inspection for Sinopharm Group Weichida Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Amoxicillin Clavulanate Potassium Tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 5, 2021)
- Company Name: Sinopharm Group Weichida Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Amoxicillin Clavulanate Potassium Tablets
- Inspection Finding: Compliant with drug standards

Company: https://www.globalkeysolutions.net/companies/sinopharm-group-weichida-pharmaceutical-co-ltd/6d30d149-8930-4496-a20e-c82d8224efcc/